Patents by Inventor Ursula Petzold

Ursula Petzold has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination of anticholinergics and leukotriene receptor antagonists for the treatment of respiratory diseases
    Patent number: 8268864
    Abstract: Pharmaceutical compositions comprising an anticholinergic and at least one leukotriene inhibitor for treatment of respiratory diseases, including allergic rhinitis, bronchial asthma, COPD and common cold, and methods of treatment.
    Type: Grant
    Filed: March 16, 2006
    Date of Patent: September 18, 2012
    Assignee: Meda Pharma GmbH & Co. KG
    Inventors: Beatrix Fyrnys, Torsten Hoffmann, Mario Weingart, Istvan Szelenyi, Peter Jurgen Cnota, Ullrich Munzel, Ursula Petzold, Joachim Maus
  • Treatment of colorectal polyps with imidazoquinoline derivatives
    Patent number: 8008319
    Abstract: The invention relates to treating colorectal polyps and precancercerous colorectal changes by topical administration of immunomodulating drugs of the imidazoquinoline family, such as imiquimod (1-(2-methylpropyl)-1H-imidazo[4,5-c]quinolin-4-amine), resiquimod (4-amino-?,?-dimethyl-2-ethoxymethyl-1H-imidazo[4,5-c]quinoline-1-ethanol), sotirimod (2-methyl-1-(2-methylpropyl)-1H-imidazo[4,5-c][1,5]naphthyridin-4-amine).
    Type: Grant
    Filed: January 14, 2009
    Date of Patent: August 30, 2011
    Assignee: Meda Pharma GmbH & Co. KG
    Inventors: Joachim Maus, Istvan Szelenyi, Ursula Petzold
  • PREVENTION AND TREATMENT OF COLORECTAL CARCINOMAS WITH IMIDAZOQUINOLINE DERIVATIVES
    Publication number: 20090182005
    Abstract: The invention relates to treating of colorectal diseases such as polyps, precancerous stages, and prevention and adjuvant treatment of colorectal cancer by topical administration of immunomodulating drugs of the imidazoquinoline family, such as imiquimod (1-(2-methylpropyl)-1H-imidazo[4,5-c]quinolin-4-amine), resiquimod (4-amino-?,?-dimethyl-2-ethoxymethyl-1H-imidazo[4,5-c]quinoline-1-ethanol), sotirimod (2-methyl-1-(2-methylpropyl)-1H-imidazo[4,5-c][1,5]naphthyridin-4-amine).
    Type: Application
    Filed: January 14, 2009
    Publication date: July 16, 2009
    Applicant: MEDA Pharma GmbH & Co. KG
    Inventors: Joachim Maus, Istvan Szelenyi, Ursula Petzold
  • Combination of anticholinergics and leukotriene receptor antagonists for the treatment of respiratory diseases
    Publication number: 20060211729
    Abstract: Pharmaceutical compositions comprising an anticholinergic and at least one leukotriene inhibitor for treatment of respiratory diseases, including allergic rhinitis, bronchial asthma, COPD and common cold, and methods of treatment.
    Type: Application
    Filed: March 16, 2006
    Publication date: September 21, 2006
    Applicant: MEDA Pharma GmbH & Co. KG
    Inventors: Beatrix Fyrnys, Torsten Hoffmann, Mario Weingart, Istvan Szelenyi, Peter Cnota, Ullrich Munzel, Ursula Petzold, Joachim Maus
  • Treatment of rhinitis with anticholinergics alone or in combination with antihistamines, phosphodiesterase 4 inhibitors, or corticosteroids
    Publication number: 20050222102
    Abstract: The present invention provides novel combinations comprising a topical anticholinergic drug alone or in combination with topically administered antihistamines, topically or orally administered phosphodiesterase 4 inhibitors or topical corticosteroids for the treatment of rhinitis of various origins. It further comprises presentation of these combinations in locally applied formulations and includes various pharmaceutical formulations suitable for topical application, e.g. nasal sprays, nasal drops, emulsions, pastes, creams and gels.
    Type: Application
    Filed: February 7, 2005
    Publication date: October 6, 2005
    Applicant: Sofotec GmbH & Co. KG
    Inventors: Joachim Maus, Ursula Petzold, Istvan Szelenyi, Torsten Hoffmann, Mario Weingart